Use of Magnetic Resonance Imaging to Quantify Fat and Steatosis
in the Pancreas in Patients after Bariatric Surgery: a
Retrospective Study

J 2022

Use of Magnetic Resonance Imaging to Quantify Fat and Steatosis in the Pancreas in Patients after Bariatric Surgery: a Retrospective Study

BLAHO, Martin, Jitka MACHACKOVA, Petr DÍTĚ, Pavol HOLECZY, Petr SEDIVY et. al.

Základní údaje

Originální název

Use of Magnetic Resonance Imaging to Quantify Fat and Steatosis in the Pancreas in Patients after Bariatric Surgery: a Retrospective Study

Autoři

BLAHO, Martin (203 Česká republika), Jitka MACHACKOVA (203 Česká republika), Petr DÍTĚ (203 Česká republika, domácí), Pavol HOLECZY, Petr SEDIVY (203 Česká republika), Robert PSAR (203 Česká republika), Zdenek SVAGERA (203 Česká republika), Dominik VILIMEK (203 Česká republika), Daniel TOMAN (203 Česká republika), Ondrej URBAN (203 Česká republika) a Marek BUZGA (203 Česká republika)

Vydání

OBESITY SURGERY, NEW YORK, SPRINGER, 2022, 0960-8923

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30219 Gastroenterology and hepatology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 2.900

Kód RIV

RIV/00216224:14110/22:00128219

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1007/s11695-022-06278-4

UT WoS

000859286600001

Klíčová slova anglicky

Obesity; Bariatric surgery; Metabolic syndrome; Pancreatic steatosis

Štítky

14110213, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 23. 1. 2023 12:39, Mgr. Tereza Miškechová

Anotace

V originále

invasive method for diagnosing PS. We investigated the impact of metabolic syndrome (MS) on the presence of PS, differences in individuals with and without PS, and the metabolic effects of bariatric procedures. Methods Changes in anthropometric and basic biochemistry values and MS occurrence were evaluated in 34 patients with obesity who underwent a bariatric procedure. After the procedure, patients underwent MRI with manual 3D segmentation mask creation to determine the pancreatic fat content (PFC). We compared the differences in the PFC and the presence of PS in individuals with and without MS and compared patients with and without PS. Results We found no significant difference in the PFC between the groups with and without MS or in the occurrence of PS. There were significant differences in patients with and without PS, especially in body mass index (BMI), fat mass, visceral adipose tissue ( VAT), select adipocytokines, and lipid spectrum with no difference in glycemia levels. Significant metabolic effects of bariatric procedures were observed. Conclusions Bariatric procedures can be considered effective in the treatment of obesity, MS, and some of its components. Measuring PFC using MRI did not show any difference in relation to MS, but patients who lost weight to BMI < 30 did not suffer from PS and had lower overall fat mass and VAT. Glycemia levels did not have an impact on the presence of PS.

Citovat

BLAHO, Martin, Jitka MACHACKOVA, Petr DÍTĚ, Pavol HOLECZY, Petr SEDIVY, Robert PSAR, Zdenek SVAGERA, Dominik VILIMEK, Daniel TOMAN, Ondrej URBAN a Marek BUZGA. Use of Magnetic Resonance Imaging to Quantify Fat and Steatosis in the Pancreas in Patients after Bariatric Surgery: a Retrospective Study. OBESITY SURGERY. NEW YORK: SPRINGER, 2022, roč. 32, č. 11, s. 3666-3674. ISSN 0960-8923. Dostupné z: https://dx.doi.org/10.1007/s11695-022-06278-4.

@article{2249107,
   author = {Blaho, Martin and Machackova, Jitka and Dítě, Petr and Holeczy, Pavol and Sedivy, Petr and Psar, Robert and Svagera, Zdenek and Vilimek, Dominik and Toman, Daniel and Urban, Ondrej and Buzga, Marek},
   article_location = {NEW YORK},
   article_number = {11},
   doi = {http://dx.doi.org/10.1007/s11695-022-06278-4},
   keywords = {Obesity; Bariatric surgery; Metabolic syndrome; Pancreatic steatosis},
   language = {eng},
   issn = {0960-8923},
   journal = {OBESITY SURGERY},
   title = {Use of Magnetic Resonance Imaging to Quantify Fat and Steatosis in the Pancreas in Patients after Bariatric Surgery: a Retrospective Study},
   url = {https://link.springer.com/article/10.1007/s11695-022-06278-4},
   volume = {32},
   year = {2022}
}

TY  - JOUR
ID  - 2249107
AU  - Blaho, Martin - Machackova, Jitka - Dítě, Petr - Holeczy, Pavol - Sedivy, Petr - Psar, Robert - Svagera, Zdenek - Vilimek, Dominik - Toman, Daniel - Urban, Ondrej - Buzga, Marek
PY  - 2022
TI  - Use of Magnetic Resonance Imaging to Quantify Fat and Steatosis in the Pancreas in Patients after Bariatric Surgery: a Retrospective Study
JF  - OBESITY SURGERY
VL  - 32
IS  - 11
SP  - 3666-3674
EP  - 3666-3674
PB  - SPRINGER
SN  - 09608923
KW  - Obesity
KW  - Bariatric surgery
KW  - Metabolic syndrome
KW  - Pancreatic steatosis
UR  - https://link.springer.com/article/10.1007/s11695-022-06278-4
N2  - invasive method for diagnosing PS. We investigated the impact of metabolic syndrome (MS) on the presence of PS, differences in individuals with and without PS, and the metabolic effects of bariatric procedures. Methods Changes in anthropometric and basic biochemistry values and MS occurrence were evaluated in 34 patients with obesity who underwent a bariatric procedure. After the procedure, patients underwent MRI with manual 3D segmentation mask creation to determine the pancreatic fat content (PFC). We compared the differences in the PFC and the presence of PS in individuals with and without MS and compared patients with and without PS. Results We found no significant difference in the PFC between the groups with and without MS or in the occurrence of PS. There were significant differences in patients with and without PS, especially in body mass index (BMI), fat mass, visceral adipose tissue ( VAT), select adipocytokines, and lipid spectrum with no difference in glycemia levels. Significant metabolic effects of bariatric procedures were observed. Conclusions Bariatric procedures can be considered effective in the treatment of obesity, MS, and some of its components. Measuring PFC using MRI did not show any difference in relation to MS, but patients who lost weight to BMI < 30 did not suffer from PS and had lower overall fat mass and VAT. Glycemia levels did not have an impact on the presence of PS.
ER  -

BLAHO, Martin, Jitka MACHACKOVA, Petr DÍTĚ, Pavol HOLECZY, Petr SEDIVY, Robert PSAR, Zdenek SVAGERA, Dominik VILIMEK, Daniel TOMAN, Ondrej URBAN a Marek BUZGA. Use of Magnetic Resonance Imaging to Quantify Fat and Steatosis in the Pancreas in Patients after Bariatric Surgery: a Retrospective Study. \textit{OBESITY SURGERY}. NEW YORK: SPRINGER, 2022, roč.~32, č.~11, s.~3666-3674. ISSN~0960-8923. Dostupné z: https://dx.doi.org/10.1007/s11695-022-06278-4.

Podrobný výpis o publikaci